Device Sales was Nexalin Technology’s largest product and service line in fiscal 2025, bringing in $272.00K of $603.29K (45%).
| Product and Service | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Device Sales | $2.33M | — | $111.00K | $272.00K | |
| Licensing Fee | $158.38K | $164.16K | $139.00K | $98.23K | |
| Equipment | $53.56K | $54.60K | $75.65K | $178.08K | |
| Royalty Fee | $48.96K | — | — | — | |
| Other | $52.82K | $2.74K | $11.79K | $54.98K | |
| Total | $2.64M | $221.50K | $337.44K | $603.29K |
Nexalin Technology brought in $603.29K from its four product and service lines in fiscal 2025, the year ended December 31, 2025. That is less than the $983.90K it reports by geography, so these lines do not cover all of its revenue. Device Sales was the largest at $272.00K (45.1%), ahead of Equipment at $178.08K (29.5%) and Licensing Fee at $98.23K (16.3%). The remaining line, Other, brought in $54.98K.
Compared with fiscal 2024, Other grew fastest, up 366.4% to $54.98K, while Licensing Fee fell the most, down 29.3% to $98.23K.
Nexalin Technology stopped reporting Royalty Fee as a separate line after fiscal 2022, when it brought in $48.96K.
China was Nexalin Technology’s largest region in fiscal 2025, bringing in $380.60K of $983.90K (39%).
| Geography | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| China | $2.42M | $7.23K | $170.50K | $380.60K | |
| International | — | — | $170.50K | $380.60K | |
| United States | $227.08K | $214.27K | $166.95K | $222.69K | |
| Total | $2.64M | $221.50K | $507.94K | $983.90K |
Nexalin Technology brought in $983.90K from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 93.7% from $507.94K in fiscal 2024. China was the largest at $380.60K (38.7%), ahead of International at $380.60K (38.7%) and United States at $222.69K (22.6%).
Compared with fiscal 2024, China grew fastest, up 123.2% to $380.60K. Every region above 2% of revenue grew.
Nexalin Technology began breaking out International in fiscal 2024, when it brought in $170.50K.
Nexalin Technology (NXL) reports its revenue by product and service and by geography. In fiscal 2025, Device Sales was its largest product and service line, bringing in $272.00K (45.1% of the total), followed by Equipment at $178.08K (29.5%).
Device Sales was Nexalin Technology's largest product and service line in fiscal 2025, bringing in $272.00K, or 45.1% of the $603.29K total across its four product and service lines.
China was Nexalin Technology's largest region in fiscal 2025, bringing in $380.60K, or 38.7% of the $983.90K total across its three regions.
Among Nexalin Technology's product and service lines that make up at least 2% of revenue, Other grew fastest in fiscal 2025, up 366.4% from $11.79K to $54.98K.
Every figure comes from Nexalin Technology's annual financial filings, as reported. Each line keeps the name Nexalin Technology gives it, and years follow its fiscal calendar.
Nexalin Technology's revenue by product and service goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.